SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-21-000994
Filing Date
2021-08-05
Accepted
2021-08-05 18:11:00
Documents
1
Period of Report
2021-07-26

Document Format Files

Seq Description Document Type Size
1 virpax_fm4jul262021.html 4  
1 virpax_fm4jul262021.xml 4 3737
  Complete submission text file 0000905718-21-000994.txt   5186
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Issuer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VIRPAX PHARMACEUTICALS 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address
Dubin Michael F (Reporting) CIK: 0001876497 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40064 | Film No.: 211149902